PT UBC Medical Indonesia Tbk (IDX:LABS)

IDX:LABS Ratios and Metrics

Market cap in millions IDR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	572,750	541,150	529,300	-	-	-
Market Cap Growth	27.19%	2.24%	-	-	-	-
Enterprise Value	581,163	543,513	545,030	-	-	-
Last Close Price	145.00	137.00	134.00	-	-	-
PE Ratio	47.46	40.07	179.29	-	-	-
PS Ratio	2.78	2.72	3.59	-	-	-
PB Ratio	3.75	3.55	3.82	-	-	-
P/TBV Ratio	3.84	3.66	3.97	-	-	-
P/FCF Ratio	-	62.33	-	-	-	-
P/OCF Ratio	34.37	23.64	-	-	-	-
EV/Sales Ratio	2.82	2.73	3.69	-	-	-
EV/EBITDA Ratio	19.20	16.47	25.81	-	-	-
EV/EBIT Ratio	32.08	26.69	60.88	-	-	-
EV/FCF Ratio	-29517.08	62.61	-	-	-	-
Debt / Equity Ratio	0.18	0.18	0.26	0.84	0.41	2.82
Debt / EBITDA Ratio	0.89	0.83	1.68	2.63	1.54	2.31
Debt / FCF Ratio	-	3.17	-	-	-	-
Net Debt / Equity Ratio	0.06	-0.09	-0.05	0.77	0.39	1.57
Net Debt / EBITDA Ratio	0.28	-0.41	-0.31	2.45	1.54	1.32
Net Debt / FCF Ratio	-427.29	-1.57	0.32	-1.10	-1.02	-0.45
Asset Turnover	0.96	0.92	0.81	1.02	0.92	-
Inventory Turnover	1.58	1.58	1.38	1.77	1.70	-
Quick Ratio	0.98	1.02	1.18	0.41	0.30	0.23
Current Ratio	2.75	2.53	3.02	1.23	0.99	0.70
Return on Equity (ROE)	8.22%	9.28%	3.14%	4.52%	10.00%	-
Return on Assets (ROA)	5.26%	5.90%	3.08%	2.71%	2.08%	-
Return on Invested Capital (ROIC)	9.06%	11.59%	4.56%	2.68%	4.73%	1.55%
Return on Capital Employed (ROCE)	11.60%	13.10%	5.90%	8.30%	7.00%	28.60%
Earnings Yield	2.11%	2.50%	0.56%	-	-	-
FCF Yield	-0.00%	1.60%	-3.87%	-	-	-
Buyback Yield / Dilution	-	-	-67.78%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.